Pacer Advisors
LMAT icon

Pacer Advisors’s LeMaitre Vascular LMAT Stock Holding History

Pacer Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
2,554
+382
+18% +$39.2K ﹤0.01% 1737
2026
Q1 		$237K Buy
2,172
+681
+46% +$64.9K ﹤0.01% 1709
2025
Q4 		$121K Sell
1,491
-168
-10% -$14.5K ﹤0.01% 2362
2025
Q3 		$145K Buy
1,659
+541
+48% +$48.3K ﹤0.01% 2081
2025
Q2 		$92.8K Sell
1,118
-1,112
-50% -$92.9K ﹤0.01% 2535
2025
Q1 		$187K Sell
2,230
-720
-24% -$67K ﹤0.01% 1783
2024
Q4 		$272K Buy
2,950
+228
+8% +$21.9K ﹤0.01% 1802
2024
Q3 		$253K Sell
2,722
-11
-0.4% -$953 ﹤0.01% 1805
2024
Q2 		$225K Buy
2,733
+1,205
+79% +$88.5K ﹤0.01% 1824
2024
Q1 		$101K Buy
1,528
+1,205
+373% +$74.4K ﹤0.01% 2719
2023
Q4 		$18.3K Buy
+323
New +$16.9K ﹤0.01% 3327
2023
Q3 		– Sell
-577
Closed -$38.8K – 2642
2023
Q2 		$38.8K Buy
+577
New +$35.2K ﹤0.01% 3166

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pacer Advisors's LMAT Position: Q2 2026 in Review

Pacer Advisors increased its LeMaitre Vascular (LMAT) stake by 18% in Q2 2026, buying an estimated $39.2K and bringing the position to 2,554 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

Pacer Advisors first reported a position in LMAT in Q2 2023 and has held it in 12 quarters since. The position peaked at $272K in Q4 2024. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Pacer Advisors held 2,554 shares of LeMaitre Vascular worth $245K as of Q2 2026.
  • Pacer Advisors bought 382 LeMaitre Vascular shares in Q2 2026, an estimated $39.2K.
  • LeMaitre Vascular made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1737 holding.
  • Pacer Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 12 quarters since.
  • Pacer Advisors's LeMaitre Vascular position peaked at $272K in Q4 2024.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.